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Abstract 
Background 
Visual information comprises one of the most salient sources of information used to control 
walking and the dependence on vision to maintain dynamic stability increases following a 
stroke. We hypothesize, therefore, that rehabilitation efforts incorporating visual cues may be 
effective in triggering recovery and adaptability of gait following stroke. This feasibility trial 
aims to estimate probable recruitment rate, effect size, treatment adherence and response to 
gait training with visual cues in contrast to conventional overground walking practice 
following stroke. 
Methods/design 
A 3-arm, parallel group, multi-centre, single blind, randomised control feasibility trial will 
compare overground visual cue training (O-VCT), treadmill visual cue training (T-VCT), and 
usual care (UC). Participants (n = 60) will be randomly assigned to one of three treatments by 
a central randomisation centre using computer generated tables to allocate treatment groups. 
The research assessor will remain blind to allocation. Treatment, delivered by 
physiotherapists, will be twice weekly for 8 weeks at participating outpatient hospital sites for 
the O-VCT or UC and in a University setting for T-VCT participants. 
Individuals with gait impairment due to stroke, with restricted community ambulation (gait 
speed <0.8m/s), residual lower limb paresis and who are able to take part in repetitive 
walking practice involving visual cues (i.e., no severe visual impairments, able to walk with 
minimal assistance and no comorbid medical contraindications for walking practice) will be 
included. 
The primary outcomes concerning participant enrolment, recruitment, retention, and health 
and social care resource use data will be recorded over a recruitment period of 18 months. 
Secondary outcome measures will be undertaken before randomisation (baseline), after the 
eight-week intervention (outcome), and at three months (follow-up). Outcome measures will 
include gait speed and step length symmetry; time and steps taken to complete a 180° turn; 
assessment of gait adaptability (success rate in target stepping); timed up and go; Fugl-Meyer 
lower limb motor assessment; Berg balance scale; falls efficacy scale; SF-12; and functional 
ambulation category. 
Discussion 
Participation and compliance measured by treatment logs, accrual rate, attrition, and response 
variation will determine sample sizes for an early phase randomised controlled trial and 
indicate whether a definitive late phase efficacy trial is justified. 
Trial registration 
Clinicaltrials.gov NCT01600391. 
Keywords 
Gait, Rehabilitation, Stroke, Vision 
Background 
Recovery of walking function is a major goal of rehabilitation after stroke. Although many 
patients regain a basic locomotor pattern, one study has reported that only 7% of patients 
discharged from rehabilitation are able to walk safely in the community [1]. A further study 
suggests that as many as 50% of stroke patients discharged into the community will fall and 
that a large proportion of these falls will occur during manoeuvres in which the basic walking 
pattern needs to be adapted, such as in turning [2]. Recent studies have postulated that 
impairments in gait which persist after stroke, such as diminished speed, asymmetries in step 
lengths and gait phase durations, may have an underlying impoverished ability to adapt the 
gait pattern as required to mobilize independently [3]. Hence, the incidence of falls after 
stroke may be due to impaired ability to flexibly adapt an already impoverished coordination 
pattern during straight walking [4] in order to turn, step over an obstacle, target a safe foot-
placement, or alter speed as needed for independent community ambulation [3]. 
Current approaches to rehabilitation of gait following stroke are varied, based on different 
models of motor physiology and disease recovery, but most share targeting motor 
impairments during straight walking only as opposed to adaptive walking ability [5]. Overall, 
evidence indicates that current rehabilitation approaches have only modest effects on 
impairment and activity [6,7]. Therefore, new more effective treatments need to be developed 
and tested within robust, early phase studies. Treatments should be supported by a sound 
theoretical basis; specifically, by an understanding of the mechanisms which cause gait 
deficits and proposed treatment effects [7]. 
Evidence from the motor learning literature indicates that effective neurorehabilitation 
requires task-specific practice that should be varied, intensive [7], and driven by a 
combination of extrinsic movement goals and implicit knowledge of movement control [8]. A 
recent synthesis of existing evidence further suggests that task-specific practice of walking 
which targets restoration of gait coordination patterns (temporal and spatial symmetry) may 
be beneficial in improving overall walking function [4]. The goal of normalizing walking 
patterns, particularly symmetry, is controversial given enduring neuromuscular asymmetries 
after stroke [9]. However, meta-analysis indicates that interventions that show most promise 
for improvements in walking function (task-specific locomotor practice and auditory cueing) 
both involve repetition of a more normative gait pattern, while the least beneficial (ankle-foot 
orthoses/functional electrical stimulation and exercise) do not explicitly practice a normative 
gait pattern [4]. The findings from the systematic examination of the evidence base lend 
support to the notion that repeated exposure to normalized movement patterns could bring 
about positive changes in motor control [10,11] and support the development of interventions 
that enable patients to undertake intensive practice of functional tasks in a manner that drives 
an optimised movement pattern. 
Rehabilitation approaches identified as showing the most promise for eliciting normalized 
gait coordination patterns utilised auditory cues as extrinsic movement goals [4]. While there 
are good indications that stroke survivors are able to adjust gait coordination in response to 
auditory cues [12], some studies have shown that visual cues may be more effective in 
triggering gait adjustments in healthy participants walking straight [13]. 
Current understanding of motor control of locomotion indicates that visual information 
comprises one of the most important and salient sources of information used during walking 
[4,14] and that stroke survivors have been reported to become more dependent on vision to 
maintain dynamic stability [15]. Paradigms involving walking in response to visual cues have 
recently begun to be used to investigate functional walking tasks, including turning and 
obstacle avoidance, in various patient populations, both overground and on a treadmill 
[13,16-18]. Despite numerous small experimental studies reporting the potential efficacy of 
using visual cues to enhance gait function, to date, there have been no robust clinical trials of 
these interventions that we are aware of. 
Based on the current understanding of motor control of walking and stroke rehabilitation, we 
hypothesize that visual cues would be more effective in triggering gait recovery and 
adaptability following stroke than interventions not including visual cues. It is hypothesized 
that anticipated improvements to functional gait may be derived from task-specific practice of 
regulating changes in the relation between the base of support and the centre of mass 
occurring when step widths and lengths change, which is crucial for dynamic balance control. 
The study reported here comprises an early phase pilot randomised controlled trial (RCT) 
aiming to examine the feasibility of a trial comparing task-specific locomotor practice 
incorporating visual cues to usual care rehabilitation, which does not include visual cues. 
Specifically, the study aims to: 
1. Characterise participants who are included and excluded into the trial from four NHS 
trusts in the West Midlands. 
2. Provide an estimation of recruitment rates to the trial across the multiple sites. 
3. Estimate the adherence of participants allocated to the visual cue training (VCT) to the 
prescribed dose. 
4. Present the completeness of proposed outcome data. 
5. Calculate sample sizes for a subsequent definitive trial, based on measured changes in 
performance for usual care and VCT intervention groups. 
6. Determine participant tolerance of the VCT intervention. 
7. Determine therapist acceptability for delivering the VCT interventions. 
8. Collate health and social care resource data to inform data collection methods for an 
economic evaluation in the subsequent definitive trial. 
Methods 
Design 
This is a pilot, multi-centre, randomised [1:1:1], stratified by gait speed (Severe group: <0.4 
m/s; Moderate group: between 0.4 m/s and 0.8 m/s [19]), controlled trial with three parallel 
groups and single-blind assessment conducted in the UK (four sites). 
Randomisation 
The randomisation will be created using StataSEv9 (StataCorp, College Station, TX, USA) 
statistical software with a 1:1:1 allocation using random permuted blocks of varying size (for 
unpredictable allocation sequence [20]), prepared by the Nottingham Clinical Trials Unit 
(NCTU) statistician and held on a secure server. To obtain balanced groups on severity, block 
randomisation will be used to stratify participants into two groups according to overground 
gait speed (Severe group: <0.4 m/s; Moderate group: between 0.4 m/s and 0.8 m/s [19]). 
Participants will be randomly assigned to one of three treatment groups by means of a web-
based randomisation system accessed by a researcher after obtaining consent and performing 
baseline assessments. Participants and therapists will not be blinded to the intervention 
allocation. The treating therapist will be notified of treatment allocation directly from the 
NCTU by email. To preserve allocation concealment [20], the independent assessor 
responsible for collecting the outcome measures will receive only blinded confirmation of 
randomisation. The assessor will record a guess of participants’ group allocation for later 
examination of the success of blinding. 
The sequence from screening, enrolment (provision of written informed consent) and 
randomisation is represented in a flow diagram Figure 1. 
Figure 1 Trial design flow diagram. 
Participants 
Combined inclusion and exclusion criteria are as follows: 
• Community dwelling post-stroke participants over 18 years of age identified at 
discharge from inpatient acute wards and at referral to community and outpatient 
services. 
• Able to provide informed consent and eligible to receive formal gait rehabilitation as 
indicated by: 
○ Gait speed <0.8m/s corresponding with limited community ambulation ability [19]; 
○ Residual paresis in the lower limb (Fugl-Meyer [21] lower limb score less than 34); 
○ A premorbid (retrospective) modified Rankin Scale [22] score of greater than 3; 
○ Without gait deficits attributable to non-stroke pathology. 
 
• Able to take part in practice of walking including visual cues as indicated by: 
○ Walking with minimal assistance, functional ambulation category [23] of 3 or more; 
○ Ability to follow a three-step command (as assessed by modified mini-mental status 
exam); 
○ Without visual impairments preventing use of visual cue training. 
 • Medically stable to take part in walking rehabilitation as indicated by: 
○ Without concurrent progressive neurologic disorder, acute coronary syndrome, 
severe heart failure, confirmed or suspected lower-limb fracture preventing 
mobilization; 
○ Not requiring palliative care. 
 
Patient characteristics including stroke date and lesion location, demographics, Sheffield 
screening test [24], mini mental state examination [25], pre-morbid modified Rankin Scale 
[22], and visual attention (Apple Test) [26] will be recorded. 
Interventions 
This study will contrast the feasibility and potential efficacy of two forms of VCT to usual 
care walking (UC) rehabilitation; overground VCT walking (O-VCT) and treadmill-based 
VCT (T-VCT). In T-VCT, a force-instrumented treadmill (CMill, Forcelink, NL, USA) will 
be used to illuminate footfall targets at specified locations 2–3 steps in advance, in line with 
current knowledge of gaze behaviour during locomotion [27] according to gait event 
detection of the ongoing gait cycle [28]. In O-VCT, therapists will manually place footfall 
target at specified locations, according to the baseline gait assessment, along an overground 
walkway. 
Both VCT interventions are designed to target the essential control and functional 
requirements of walking, namely (1) speed, (2) symmetry (equality of step length), and (3) 
adaptability to behavioural goals of the participant and environmental constraints, including 
abilities for turning and shortening, lengthening or narrowing (e.g., tandem walking) of steps 
[29]. The potential efficacy, feasibility and acceptability of both O-VCT and T-VCT 
treatment modalities are being investigated because some studies [7,30] have indicated 
support for mechanically aided rehabilitation approaches due to the capacity to deliver high 
dosage and high intensity training protocols incorporating motor learning and motor control 
theoretical perspectives. However, the efficacy of electromechanically aided walking practice 
has not been established and so they are not often offered as part of current practice [31-34]. 
There will be three treatment arms all of which share the same frequency, duration and 
intensity in terms of encouraging therapists to maintain equal session durations and same 
intensity of continuous walking. Participants will receive walking practice for one hour, 2 
times per week, for 8 weeks duration. The target exercise capacity is 20 minutes of 
continuous, independent walking, with symmetrical step length. A resource usage log will 
record all other aspects of therapy such as occupational therapy, for which participants are 
referred and will continue to receive, irrespective of treatment allocation. 
O-VCT and UC will be delivered in four participating hospital settings embedded within 
current service provision. Only one specialized treadmill (CMill, Forcelink, NL, USA) for T-
VCT is available to the study and so the feasibility of this treatment is being assessed through 
treatment delivery at one regional treatment site (within a mean 11 mile radius of 
participating NHS sites delivering O-VCT and UC treatment arms) at the University of 
Birmingham. Patients recruited from the participating hospitals will travel to the University 
to receive this arm of training if they are randomised to it. This is not additional travel, but in 
lieu of their normal transfer to hospital for treatment. This model of a regional treatment 
centre is in line with the provision of other specialist rehabilitation services such as functional 
electrical stimulation falls efficacy scale and gait assessment in this part of the UK. 
Treating therapists will receive training and a detailed treatment manual to promote 
consistency between therapists and sites. Adherence to the intervention by therapists will be 
assessed during their involvement in the trial by A. Wimperis and K. Hollands through video 
observation at weeks 2 and 6 of each therapists’ first treatment period. Further training for the 
therapist will be provided, if necessary, to improve compliance with treatment protocols. The 
involvement of different therapists and different sites promotes generalizability, providing 
multiple viewpoints regarding the treatment and its feasibility for delivery across different 
modes of service provision. 
VCT interventions (Figure 2 and Table 1) 
Figure 2 Illustration of training target placement for O-VCT and T-VCT. (a) O-VCT 
symmetry, (b) O-VCT adaptability, (c) O-VCT turning, (d) T-VCT symmetry, (e) T-VCT 
adaptability, (f) T-VCT turning. 
Table 1 Visual cue training (VCT): treatment progression 
Progression Treatment goal categories 
treatment 
phase 
(sessions) 
Walking speed target Symmetry target Turning ability target Gait adaptability/ 
translation to functional 
mobility 
Intensity 
I (1–4) Increasing walking speed 
in 10% increments, as 
tolerated, from baseline to 
the target threshold (either 
0.4m/s or 0.8m/s 
depending on initial 
SSWS) 
Improving symmetry of 
(a)step-length, (b) stance 
and swing phases in 
10% increments, as 
tolerated 
  Four 5 min bouts of 
walking to total 20 min 
of stepping with each 
bout addressing one of 
the goals at a time 
II (5–10) Increasing walking speed 
in 10% increments, as 
tolerated, from baseline to 
the target threshold (either 
0.4m/s or 0.8m/s 
depending on initial 
SSWS) 
Improving symmetry of 
step-length, stance and 
swing phases in 10% 
increments, as tolerated, 
while maintaining new 
walking speed 
10% improvement in 
turning towards ability to 
turn in two steps, 2 
seconds in either 
direction while 
maintaining new walking 
speed 
10% improvement in the 
number of failures to hit 
targets presented 
unpredictably in timing and 
location on both limbs 
while maintaining new 
walking speed 
Increase bout duration 
and decrease number 
of bouts; however, 
each goal is still 
addressed individually 
in blocks of practice 
III (11–16) Practice at maintenance of 
walking speed over 
threshold and at altering 
speed as dictated by 
varying speed of 
presentation of footfall 
targets 
Practice at maintenance 
of symmetrical stepping 
Two steps, 2 seconds in 
either direction when 
turns are unpredictable 
Able to alter stepping 
pattern to hit targets 
presented unpredictably in 
timing and location on 
either limb 
20–30 min of sustained 
*good quality stepping 
*Good quality stepping is defined as walking with spatial symmetry of stepping pattern and dynamic trunk control during adaptations to step 
length and turning. 
Self selected walking speed SSWS. 
Training of speed and symmetry 
To improve symmetry we increase the shorter step length incrementally by 10% of the 
maximum step length. Patients are presented with stepping targets (white rectangles, 8 cm 
deep x 40 cm wide (which adhere to the walkway in O-VCT or are illuminated on the 
treadmill belt in T-VCT) along a 5 m long walkway (O-VCT), or 3 m treadmill belt (T-VCT), 
to which they must aim to step on. In both VCT treatment arms, stepping targets can be seen 
at least two steps in advance in accordance with visuo-motor control literature indicating 
where healthy adults typically look while walking to targets [35]. The width of the stepping 
targets corresponds to half of the width of the walkway, allowing for self-selected width of 
stepping such that medial stabilisation strategies are not constrained while patients are being 
challenged to alter step length and speed. The depth of the targets corresponds to the 
variability in step length reported in stroke patients [36]. Participants are instructed to step on 
the targets with any part of the foot. Thus, the depth of the targets has been selected such that 
they should only be missed if the error in footfall location is greater than usual variability. 
The location of the stepping targets is predetermined according to goals for 10% increments 
in improved symmetry and altered as treatment progresses to increase intensity. The location 
of targets is calculated and prescribed to treating clinicians by the research assessor following 
baseline overground gait assessment and prior to the start of training. Prescribed targets for 
progressing speed (beyond 0.4 m/s or 0.8 m/sfor the moderate and severely impaired, 
respectively) will also be provided according to 10% increments to baseline measures. 
Participants are allowed to use a walking aid and prescribed ankle/foot orthoses or to grasp 
the therapist’s hand, wall or handrail for safety. Stepping towards increasingly symmetrical 
targets is practiced at increasing walking speed as treatment progresses (Table 1). 
Adaptability practice 
Stepping targets are placed to elicit step adjustments similar to that required in environments 
with clutter or situations requiring alterations to foot-placement or direction. Targets are 
located along the walkway/treadmill belt to elicit lengthening, shortening (±25% of baseline 
step lengths) and narrowing of paretic and non-paretic steps. In the T-VCT treatment arm, 
illuminated targets shift to elicit step alterations at varying times in the ongoing gait cycle and 
obstacles are presented in red and white stripes to be avoided (Figure 2e). Thus with the 
exception of obstacle avoidance in T-VCT and the ability to practice changes to walking in 
time-critical manner, the number and magnitude of each type of step alteration are the same 
across both VCT treatment arms. 
Turning practice 
Turning is performed by walking between targets located 1 m apart alternately on the left and 
to the right of the walkway/treadmill belt. Participants are instructed to ‘turn to walk between 
the obstacles’ in such a fashion as to slalom their way across the walkway/treadmill belt. In 
O-VCT, once the end of the path is reached, participants practice a 180° turn using a 
horizontal marker to cue foot placement according to a two-step turn seen in healthy adults, 
[35,37,38]. Participants then slalom their way back down the path. 
Each session will consist of 5 min each of warm up and stretching, 20–30 min (plus 10 min 
for rests as required) overground walking practice training programme and a 5 min cool-
down. Each of the components of walking ability (symmetry, adaptability and turning) is 
practiced in blocks at increasing speed as treatment intensity progresses. Thus, walking is 
practiced in accordance with current recommendations of motor learning [8,39], i.e., with 
many repetitions with increasing intensity, variation of parameters, in response to external 
demands and using implicitly known (visuo-motor) control of the gait cycle [35]. 
Treatment will progress in phases layering practice of walking speed, symmetry, adaptability 
and turning in bouts of practice, as detailed in Table 1. Participants will continue to the next 
treatment phase even in cases where goals have not been met. 
Walking speed in the O-VCT arm will be monitored and progressed by timing walks, with 
therapists’ use of a stopwatch, and feedback to the participant. T-VCT treatment will be 
delivered by an experienced, HPC registered research therapist. The CMill uses an 
assessment of each footfall to determine the timing and location of visual cues projected as 
light targets shone 2–3 steps ahead on the treadmill. The location of visual cues and 
progression of treatment will therefore be pre-programmed according to baseline gait 
parameters in the same manner as for the O-VCT treatment. A safety harness is worn at all 
times during T-VCT treatment. 
 
Insert Figure 2 
Usual care 
The purposes of the UC group are to provide (1) a task-specific-based intervention that does 
not include use of visual cues specifically designed to influence quality or adaptability of 
gait; (2) an equal number of interactions and time spent with a physical therapist to minimize 
any potential for bias due to differential exposure and minimize the risk for differential loss 
to follow-up; and (3) a credible training program so that the participants would consider 
themselves involved in meaningful therapy activity. UC is standard NHS physiotherapy, 
broadly defined as a task-specific-based intervention that may involve walking overground or 
on a treadmill; components of gait (such as weight shifting or initiation); exercises aimed at 
improving upper or lower extremity strength; balance and coordination; prescription of 
assistive devices (such as orthotics or walking aides). UC may involve any standard 
equipment or objects such as cones or beanbags, which may be incorporated into walking 
practice for functional use, e.g., picking up. These objects will not be used specifically as 
visual cues for foot placement, symmetry or timing of gait, or by way of aiming to avoid or 
hit targets. The content of UC treatment will be captured by a treatment log for the purpose of 
capturing UC physiotherapy specifically used to influence walking. Therapists complete the 
log by ticking relevant categories for environment, aids and equipment used, activities 
undertaken, facilitation and feedback provided, and duration of each treatment session. 
Primary outcomes 
Primary outcome measures for this early phase trial focus upon the feasibility and safety of 
treatment. In order to determine whether a large late phase trial is warranted, we are 
investigating recruitment, participation, compliance, and safety of the interventions. Outcome 
measures therefore include: 
1. The numbers of patients willing to be recruited into both control and VCT groups. 
2. The willingness of physiotherapists at each collaborating site to enrol patients, i.e., the 
number of potentially eligible participants referred to the study. 
3. The numbers of patients who do not complete the allocated treatment, thus dropping out of 
the study, and the reasons for dropping out. 
4. Completeness of outcome data, i.e., percentage of patients with no missing values in 
outcome assessments. 
5. Number and type of adverse events that can be directly attributed to the project 
intervention. 
Secondary outcome measures 
Potential for efficacy will be assessed through measures reflecting the primary aims of the 
intervention, i.e., speed and symmetry, turning ability, and adaptability of walking. 
Primary measures of walking ability: 
1. Gait speed: Proportion of participants achieving a gait speed of 0.4 m/s and 0.8 m/s, 
measured during a 10 m walk [40]. Perry et al. [19] have shown that these gait speed 
classifications correspond to walking abilities in the community, with a gait speed of <0.4 
m/s for household walkers, 0.4–0.8 m/s for limited community walkers, and >0.8 m/s for 
community walkers. It has been demonstrated that progressing from one of these 
classifications to the next correlates with improvement in physical functioning and quality of 
life [41] and these categories also correspond with changes in the functional ambulation 
category, a categorical scale rating level of skill in functional ambulation [23]. 
2. Symmetry and turning ability: Time taken (s) and number of steps to complete a 180° turn 
will be measured on the GaitRite instrumented walkway. Time taken to turn will be 
calculated as the difference (in time) between the first footfall over a line (tape mark) on the 
pressure sensitive walkway delineating where to turn and the first footfall over the line on the 
return walk. Longer time to turn and increased number of steps to turn have all been 
identified as performance measures which may be indicative of difficulty turning and 
increased falls risk [37,42]. Additionally, spatial-temporal gait parameters will be measured 
during walking over the GaitRite to quantify symmetry of left and right steps. Stepping 
strategies during turning will be measured through gait parameters calculated by GaitRite 
software including step width, step length (relative to line of progression) [43], and single 
support time during turning steps. 
3. Adaptability of gait: The number of times participants fail to hit stepping targets arranged 
to cue varying (baseline step length ±30% and medial) foot placements on the overground 
walkway (as previously described and illustrated in Figure 2). A target is classified as missed 
if the participant is visually observed to be unable to place the whole foot accurately on the 
target independently and safely (according to visual inspection). The assessor documents the 
number of targets missed in three consecutive passes of the walkway (a total of 48 targets 
including three attempts of each step adjustment on each side) as well as time taken to 
complete each pass of the walkway and a score for the level of supervision or assistance 
required. 
We will further explore the relationship between gait impairments and activity level measures 
of independence of functional walking in the community. Therefore, the following secondary 
outcome measures are included: 
• The timed up and go test has previously been shown to have good test-retest 
reliability in stroke patients [44,45]. The time taken with a stopwatch will be used to 
test ability to walk and turn in the context of this standardised test of everyday 
functional mobility. 
• Fugl-Meyer assessment [21] will be used to assess changes in motor and sensory 
impairment. 
• Berg balance scale [46,47] will be used to capture any effects of interventions on 
balance. 
• Overall independence of mobility in the community setting will be rated using the 
functional ambulation category [48]. 
• Falls efficacy scale [49] will be used to assess changes in confidence to walk without 
falling, which may be expected as a result of practice of adaptable walking. 
• SF-12 [50,51]. This is a short-form health survey with only 12 questions. It yields an 
8-scale profile of functional health and well-being scores, including physical 
functioning, and social, emotional, mental and general health, and has been included 
to measure effects on broader quality of life (Table 2). 
Table 2 Assessment schedule and measures 
Outcome measure Clinical 
status 
baseline Post-intervention (8 
weeks post-
randomisation) 
Follow-up (3 months 
post-randomisation) 
Stroke date and lesion 
location 
X    
Demographics X    
Sheffield screening test [34] X    
Mini mental state 
examination [35] 
X    
Premorbid modified Rankin 
Scale [19] 
X    
Visual attention – Apple test 
[36] 
X    
Gait assessment (symmetry 
measures) 
 X X X 
Gait speed (10 m walk test)  X X X 
Gait adaptability (number of 
targets missed) 
 X X X 
Timed up and go [37]  X X X 
Fugl-Meyer [18] motor 
assessment (lower limb 
extremity) 
 X X X 
Berg balance scale [38-40]  X X X 
Functional ambulation 
classification [41] 
 X X X 
Short form 12 (SF-12)  X X X 
Outcome measure Clinical 
status 
baseline Post-intervention (8 
weeks post-
randomisation) 
Follow-up (3 months 
post-randomisation) 
[42,43] 
Falls efficacy scale [44]  X X X 
Economic evaluation 
The purpose of the economic evaluation in the pilot trial is to identify all the relevant health 
and social care costs, and pilot methods for collecting cost data (data collection forms, 
questionnaires). This will provide initial cost information and enable effective resource use 
and cost data collection systems to be determined for a subsequent definitive trial. 
Data collection 
Details of all travel to and equipment used for patient therapy will be recorded and costs 
established. Therapist time spent with the patient and location of therapy will be recorded in 
order to calculate the cost of an individual session. Any additional stroke rehabilitation-
specific primary and secondary care and social services resource use information will be 
collected in a self-report log from each patient. Quality of life will also be measured using 
responses to the SF-12 at baseline, 8 weeks and 3 months. 
Analysis 
Unit costs will be applied to all items of resource use, and health and social care costs per 
patient will be estimated. Responses to the SF-12 will be converted to SF-6D scores, allowing 
the calculation of quality adjusted life years (QALYs) per patient over the 3-month period. A 
cost-consequence analysis will be undertaken presenting all costs and outcomes in a 
disaggregated form for each trial arm. Within the economic evaluation, alongside a larger 
trial, a cost-effectiveness analysis and cost-utility analysis are proposed to determine the cost 
per unit reduction in impairment, and cost per QALY gained (using the SF-6D derived from 
SF-12 responses). 
Assessment of safety and adverse event monitoring 
The risk of serious or adverse events from taking part in the study is considered low; 
however, as with conventional gait rehabilitation, there is a small possibility of injury as a 
result of a fall. No special safety assessments are planned. Clinicians will be advised that 
participant safety is paramount. Walking will be practiced within limits considered by the 
therapist to be safe at the time and targets for treatment progression will only be used as a 
guideline. In addition to the compliance of standard NHS reporting procedures, adverse 
events, including falls, will be reported immediately to the study coordinating centre via 
email using an adverse event form and then quarterly to the Trial Steering Committee (TSC) 
and Data Monitoring and Ethics Committee (DMEC). Adverse events will be reviewed 
immediately by the treating therapist and the research therapist to determine the severity, 
cause and likelihood of recurrence. Training will be discontinued if the treating therapist or 
research therapist deems continuation unsafe. 
Ethical approvals and data monitoring 
Ethical approval has been granted by the NRES Committee West Midlands (11/WM/0167). 
R&D Governance approval is provided by the University of Salford; BBC CLRN RM&G 
Consortium Trusts (284.74472.P); Heart of England NHS Foundation Trust (2011007SKE); 
South Warwickshire NHS Foundation Trust (74472); and Sandwell and West Birmingham 
Hospitals Trust (11STR07). The trial is registered on the ClinicalTrials.gov database 
(NCT01600391) and adopted by the Stroke Research Network UKCRN (ID11147). A 
combined TSC and independent DMEC will be used to monitor the trial conduct. The grant 
holding team meet to review project management on a quarterly basis with day-to-day 
management overseen by the chief investigator CI. 
Data quality is ensured both through the monitoring of the TSC and DMEC, and through the 
engagement of data services of the NCTU. The NCTU maintains the computer-based 
database of case report forms and has developed and tested the validations for entering study 
data into the database. 
Compliance to the trial protocol by participating NHS sites is ensured by provision of a 
treatment manual and training of all participating NHS therapists by the research therapist 
and assessor, as well as video observation of treatment delivery. 
Statistical analysis 
This feasibility study is designed primarily to test recruitment, retention and the completeness 
of data that could be expected within a definitive multicentre trial, hence, there will be no 
formal statistical assessment of clinical efficacy. Secondary outcome measures will be 
summarised and mean differences between the arms will be calculated and presented with 
confidence intervals to determine sample sizes for a subsequent late phase trial. No interim 
analysis will be conducted. 
Screening logs will be held centrally for each site and from which monthly recruitment rates 
will be accrued together with the percentage of participation refusals. The screening data will 
be analysed to determine characteristics of the excluded samples. The number of withdrawals 
before and after randomisation will be monitored by the NCTU together with a primary 
reason for withdrawal whenever possible. Demographic and other baseline data will be 
summarised by descriptive statistics (number, mean, standard deviation, median, minimum 
and maximum) or frequency tables, stratified by treatment. 
Compliance in terms of treatment sessions attended will be summarised by descriptive 
statistics (number, mean, standard deviation, median, minimum and maximum) or frequency 
tables, stratified by treatment. The frequency, type and duration of exercises will be 
summarised from treatment logs recorded by physiotherapists at each session. These will be 
collated after the follow-up assessment to prevent unblinding. The completeness of treatment 
log data will then be determined. Adverse event incidents will be summarised. A telephone 
interview will be conducted at the end of the patients’ participation to determine patient 
views on the VCT training. Focus group meetings will be conducted with therapists after the 
study to ascertain professional opinions regarding delivery of the interventions. Patient and 
therapist feedback will be synthesised to determine necessary changes to the interventions. 
Discussion 
Recovery of independent mobility after stroke is a major priority of rehabilitation but 
evidence indicates that current approaches have only modest effects on walking impairment 
and activity [6,7]. In accordance with the suggested need for studies in this area [7], this early 
phase trial will test the feasibility, safety and potential efficacy of two novel approaches 
which offer repetitive task-specific practice of walking in response to visually cued external 
demands designed to exploit implicitly known visuo-motor control of the gait cycle. Results 
will indicate potential response (e.g., a confidence interval indicating if, and which of the 
VCT interventions has the potential to be superior to the UC) to walking practice 
incorporating visual cues, stepping adaptability and turning practice in contrast to UC in 
community-dwelling stroke survivors. 
For clinicians, this research will help to define an evidence-based protocol for VCT within 
routine practice, which is targeted towards increased speed, improved spatial symmetry and 
dynamic gait control during adaptations to step length and turning. It is anticipated that the 
resulting improvements to functional gait will reduce dependence upon carers and promote 
physical activity and social participation for people with stroke, and further, that reduced 
health-care costs will reflect fewer falls. 
Trial status 
Recruitment began in June 2012. To date 364 stroke patients have been screened for 
eligibility, 32 potentially eligible participants have been approached for consent, and 8 have 
declined. Out of the remaining 24 eligible participants, 16 have provided consent and 8 
consents are pending; 11 participants have been randomised and 5 are awaiting baseline 
assessment prior to randomisation. 
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Figure 1: Trial flow diagram 
  
Figure 2 Illustration of training target placement for O-VCT (a) symmetry, (b) adaptability, (c) & turning and T-VCT (d) 
symmetry, (e) adaptability & (f) turning.  
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